Belgium (BE)

close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course (2019) Cavagna L, Trallero-Araguas E, Meloni F, Cavazzana I, Rojas-Serrano J, Feist E, Zanframundo G, et al. Journal article PD-L1 assessment in urothelial carcinoma: a practical approach (2019) Eckstein M, Cimadamore A, Hartmann A, Lopez-Beltran A, Cheng L, Scarpelli M, Montironi R, Gevaert T Journal article, Review article Benders' algorithm with (mixed)-integer subproblems (2019) Weninger D, Wolsey L Other publication type ARIA guideline 2019: treatment of allergic rhinitis in the German health system (2019) Klimek L, Bachert C, Pfaar O, Becker S, Bieber T, Brehler R, Buhl R, et al. Journal article Opinion of the Scientific Committee on Consumer safety (SCCS) – Opinion on the safety of cosmetic ingredient salicylic acid (CAS 69-72-7) (2019) Panteri E, Bernauer U, Bodin L, Chaudhry Q, Coenraads P, Dusinska M, Ezendam J, et al. Journal article Emotieregulatietraining bij kinderen en adolescenten (2019) Braet C, Berking M Authored book Beam-helicity asymmetries for single-hadron production in semi-inclusive deep-inelastic scattering from unpolarized hydrogen and deuterium targets (2019) Airapetian A, Akopov N, Akopov Z, Aschenauer EC, Augustyniak W, Belostotski S, Blok HP, et al. Journal article Chronic Kidney Disease and Coronary Artery Disease: JACC State-of-the-Art Review (2019) Sarnak MJ, Amann KU, Bangalore S, Cavalcante JL, Charytan DM, Craig JC, Gill JS, et al. Journal article, Review article CTCF variants in 31 individuals with a variable neurodevelopmental disorder broaden the mutational and clinical spectrum (2019) Konrad E, Nardini N, Blyth M, Prescott K, Bouman AM, Brilstra EH, Caliebe A, et al. Conference contribution Early Symptom Improvement With Risankizumab Treatment in Patients With Moderately to Severely Active Crohn's Disease: Analysis From a Phase 2 Study (2019) Feagan BG, Sandborn WJ, D'Haens GR, Panes J, Kaser A, Ferrante M, Louis E, et al. Conference contribution